The Europe Real World Evidence Solutions Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).
The European Medicines Agency has also developed guidelines for RWE studies that mandate risk-benefit data for post-authorization safety investigations. Therefore, it is anticipated that positive government actions will accelerate market expansion. Additionally, an industry alliance to develop and broaden RWE's application encourages market expansion.
Five companies, including Aetion, IQVIA, Tempus, Flatiron Health, and Syapse, cooperated in 2021 for example, to use data from EHRs, insurance claims, and several other sources outside of clinical trials. The coalition will also collaborate with pharmaceutical firms, producers of medical equipment, patient advocacy organizations, and other significant stakeholders.
This is done to encourage broader initiatives centered on the use of RWE, which, according to coalition members, aids providers, developers, and regulators in having a better understanding of the efficacy and safety of medical products. Such advances will help the market facilitate quicker access to innovative treatment alternatives, which will drive growth.
The institute stresses that realizing this vision, rooted in the Network Strategy to 2025, will encourage the creation and patient usage of better medications. Delivering this ambition will depend heavily on developing the Data Analytics and Real World Interrogation Network (DARWIN EU). It will be possible to analyze and access healthcare data from throughout the EU owing to this network. The initiative will begin in early 2022 with the development of a coordination center to onboard data partners and to direct the completion of studies required by medication regulators and, later, also sought by other stakeholders. RCT data is the main factor in initial price, reimbursement, and market access decisions in Germany because it is the sole drug-specific RWE available before market authorization. These strategies, initiatives, and collaborations are driving the growth of Real World Evidence Solutions Market in Europe.
The Germany market dominated the Europe Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,206.3 million by 2028.The UK market is anticipated to grow at a CAGR of 7.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9% during (2022 - 2028).
Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Real World Evidence Solutions Market will Hit $65.1 Billion by 2028, at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Component
By Therapeutic Area
- Oncology
- Cardiology
- Neurology
- Diabetes
- Respiratory
- Others
By End-user
- Healthcare Companies
- Healthcare Payers
- Healthcare Providers
- Others
By Application
- Drug Development & Approvals
- Medical Device Development & Approvals
- Reimbursement/Coverage & Regulatory Decision Making
- Post Market Safety & Adverse Events Monitoring
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- IBM Corporation
- Oracle Corporation
- Medpace Holdings, Inc.
- IQVIA Holdings, Inc.
- ICON plc
- PerkinElmer, Inc.
- Parexel International Corporation (Phoenix Parentco, Inc.)
- PPD, Inc. (Thermo Fisher Scientific, Inc.)
- UnitedHealth Group, Inc. (Optum, Inc.)
- Syneos Health, Inc.
TABLE 1 Europe Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 2 Europe Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 3 Europe Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 4 Europe Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 5 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Data Set Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Data Set Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 10 Europe Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 11 Europe Oncology Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Oncology Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Neurology Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Neurology Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 24 Europe Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 25 Europe Healthcare Companies Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Healthcare Companies Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 34 Europe Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 35 Europe Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
TABLE 45 Germany Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 46 Germany Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 47 Germany Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 48 Germany Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 49 Germany Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 50 Germany Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 51 Germany Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 52 Germany Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 53 Germany Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 54 Germany Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 55 UK Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 56 UK Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 57 UK Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 58 UK Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 59 UK Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 60 UK Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 61 UK Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 62 UK Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 63 UK Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 64 UK Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 65 France Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 66 France Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 67 France Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 68 France Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 69 France Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 70 France Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 71 France Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 72 France Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 73 France Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 74 France Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 75 Russia Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 76 Russia Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 77 Russia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 78 Russia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 79 Russia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 80 Russia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 81 Russia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 82 Russia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 83 Russia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 84 Russia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 85 Spain Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 86 Spain Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 87 Spain Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 88 Spain Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 89 Spain Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 90 Spain Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 91 Spain Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 92 Spain Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 93 Spain Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 94 Spain Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 95 Italy Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 96 Italy Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 97 Italy Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 98 Italy Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 99 Italy Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 100 Italy Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 101 Italy Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 102 Italy Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 103 Italy Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 104 Italy Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 105 Rest of Europe Real World Evidence Solutions Market, 2018 - 2021, USD Million
TABLE 106 Rest of Europe Real World Evidence Solutions Market, 2022 - 2028, USD Million
TABLE 107 Rest of Europe Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
TABLE 108 Rest of Europe Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
TABLE 109 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 110 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 111 Rest of Europe Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
TABLE 112 Rest of Europe Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
TABLE 113 Rest of Europe Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
TABLE 114 Rest of Europe Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
TABLE 115 Key information – IBM Corporation
TABLE 116 Key Information – Oracle Corporation
TABLE 117 Key Information – PPD, Inc.
TABLE 118 Key Information – UnitedHealth Group, Inc.
TABLE 119 Key Information – Syneos Health, Inc.
TABLE 120 Key information – IQVIA Holdings, Inc.
TABLE 121 key Information – Medpace Holdings, Inc.
TABLE 122 key Information – PerkinElmer, Inc.
TABLE 123 Key Information – PAREXEL International Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: IBM Corporation
FIG 3 SWOT analysis: Oracle Corporation
FIG 4 Swot analysis: thermo fisher scientific, inc.